About Quest Laboratories Limited
Data last updated:
Quest Laboratories Limited is a public limited company based in Dhar, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 June 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1998PLC012850. Its GSTIN is 23AAACQ1040R1ZH (Madhya Pradesh). The company holds 4 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹16.39 Cr. It is led by directors including Anil Kumar Sabarwal (Managing Director) and Tejaswini Chouhan (Whole-Time Director).
Its last annual general meeting (AGM) was held on 04 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 45 Sector III Pithampur, Dhar, Madhya Pradesh, India – 454775.
As per the financials filed for FY 2025, the company reported a revenue of ₹108.21 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹13.57 Cr (net margin 12.5%) and EBITDA of ₹20.23 Cr (EBITDA margin 18.7%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 33% over five years.
The company has about 64 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Quest Lab. As per MCA filings, the company has open charges of ₹32.3 Cr and satisfied charges of ₹4.11 Cr on record. Court records list 5 cases involving the company, including 1 filed against it; 2 cases are pending. The company has 1 deal on record (1 ipo); the latest was in May 2024. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is STG Pharmagenerics Private Limited with revenue of ₹110.75 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website questlabltd.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No. 45 Sector III Pithampur, Dhar, Madhya Pradesh, India – 454775
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Quest Laboratories Limited
The main business activity of Quest Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Quest Laboratories Limited FY 2024 filings available
Quest Laboratories Limited reported revenue of ₹108.21 Cr (up 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Quest Laboratories Limited
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 31% growth in the latest year. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Quest Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹20.23 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹13.57 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Quest Laboratories Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 12.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Quest Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Quest Laboratories Limited
Quest Laboratories Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| STG Pharmagenerics Private Limited | ₹110.75 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Mumbai, Maharashtra, India |
| Horizon Bioceuticals Pvt Ltd | ₹110.37 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Panipat, Haryana, India |
| Inventaa Industries Private Limited | ₹109.72 Cr (FY 2025) | •••• | •••• | -17.0% | •••• | Kanchikacherla, Andhra Pradesh, India |
| Novus Life Sciences Private Limited | ₹109.09 Cr (FY 2025) | •••• | •••• | 96.0% | •••• | Mumbi, Maharashtra, India |
| Chemtech Intermediates Limited | ₹109 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Vadodara, Gujarat, India |
| Quest Laboratories Limited this company | ₹108.21 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Dhar, Madhya Pradesh, India |
| Meyonex Pharmaceuticals Limited | ₹108.15 Cr (FY 2025) | •••• | •••• | -19.0% | •••• | Palghar, Maharashtra, India |
| Shiva Biogenetic Pharmaceuticals Private Limited | ₹107.81 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Solan, Himachal Pradesh, India |
| Unimed Technologies Limited. | ₹107.74 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Vadodara, Gujarat, India |
| Shivalik Remedies Private Limited | ₹107.31 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | New Delhi, Delhi, India |
| Genetek Lifesciences Private Limited | ₹107.01 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | Nagpur, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Quest Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Quest Laboratories Limited
Quest Laboratories Limited is audited by SHYAM S GUPTA & ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHYAM S GUPTA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Quest Laboratories Limited
Quest Laboratories has 7 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Sabarwal | Managing Director | 21 Feb 2022 | 4 Years 7 Months | Current |
| Tejaswini Chouhan | Whole-Time Director | 05 Mar 2021 | 5 Years 7 Months | Current |
| Amit Ramesh Chandak | Director | 10 Jan 2024 | 2 Years 9 Months | Current |
| Umendra Singh | Whole-Time Director | 01 Jul 2024 | 2 Years 3 Months | Current |
| Basant Lal Menghwani | Director | 10 Jan 2024 | 2 Years 9 Months | Current |
| Gautam Chand Kothari | Director | 10 Jan 2024 | 2 Years 9 Months | Current |
Ownership and Shareholding of Quest Laboratories Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Quest Laboratories Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Sep 2024 | Others | ₹90 Lakh | Open |
| 30 May 2022 | Hdfc Bank Limited | ₹10.05 Lakh | Open |
| 18 Sep 2017 | Hdfc Bank Limited | ₹16.51 Cr | Open |
| 31 Aug 2017 | Hdfc Bank Limited | ₹13.89 Cr | Open |
| 18 Oct 2012 | Shriram City Union Finance Limited | ₹90 Lakh | Open |
Total charge records: 10 View all charges
Deals & Funding of Quest Laboratories Limited
Quest Laboratories Limited has 1 deal on record (1 ipo); the latest was in May 2024.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2024 | IPO | ₹43.16 Cr | Investors: Persistent growth Fund, Craft Emerging Market Fund, Rajasthan Global Securities Private Limited |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Quest Laboratories Limited
Quest Laboratories Limited has 5 court cases on record: 1 filed against it, 4 where it is another party. 2 cases are pending and 3 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 1 | 1 |
| High courts | 1 | 0 | 1 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Company is another party | Pending |
| District court, Yavatmal, Maharashtra | Civil suit | Company is another party | Pending |
| District court, Bokaro, Jharkhand | Criminal complaint | Filed against the company by State of Jharkhand | Disposed |
| District court, Nizamabad, Telangana | Court case (PRC) | Company is another party | Disposed |
| District court, Nizamabad, Telangana | Criminal complaint | Company is another party | Disposed |
Full case history
All 5 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Quest Laboratories Limited
Quest Laboratories operates one associated brand: Quest Lab. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations including tablets and capsules are manufactured and FDA-approved. | questlabltd.com |
Employees and EPFO Compliance at Quest Laboratories Limited
Quest Laboratories Limited has a workforce of 64 employees as of Apr 13, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Quest Laboratories Limited
Quest Laboratories has one previous CIN (Corporate Identification Number): U24232MP1998PTC012850. The current CIN is U24232MP1998PLC012850, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232MP1998PLC012850 | Current |
| U24232MP1998PTC012850 | Previous |
Recent Activity on Quest Laboratories Limited
Quest Laboratories Limited has 18 board changes on record since 2021: 7 appointments and 11 cessations. The latest: Umendra Singh ceased to be Additional Director on 03 Sep 2024.
27 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Quest Laboratories Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Quest Laboratories Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Quest Laboratories Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Quest Laboratories Limited
Quest Laboratories has 4 GST registrations: 1 active and 3 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAACQ1040R1ZH | Madhya Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Quest Laboratories Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quest Laboratories Limited
Quest Laboratories is an active public limited company based in Dhar, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 June 1998 (28+ years old) and is registered under CIN U24232MP1998PLC012850.
Quest Laboratories reported revenue of ₹108.21 Cr for FY 2025 (up 31% YoY).
Quest Laboratories has 7 current directors:
- Anil Kumar Sabarwal - Managing Director
- Tejaswini Chouhan - Whole-Time Director
- Umendra Singh - Whole-Time Director
- Vinayak Sabarwal - Whole-Time Director
- Amit Ramesh Chandak - Director
- Basant Lal Menghwani - Director
- Gautam Chand Kothari - Director
Quest Laboratories reported a net profit of ₹13.57 Cr (net margin 12.5%) and EBITDA of ₹20.23 Cr (EBITDA margin 18.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Quest Laboratories is 22% over three years and 33% over five years. In the latest year (FY 2025) revenue rose 31%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Quest Laboratories is 23AAACQ1040R1ZH, registered in Madhya Pradesh. The company has 4 GST registrations in all, of which 1 is active and 3 are cancelled or inactive.
The CIN (Corporate Identification Number) of Quest Laboratories is U24232MP1998PLC012850. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Quest Laboratories has 5 court cases on record: 1 filed against it. 2 are pending. Most are in the district courts.
Quest Laboratories was incorporated on 01 June 1998, making it 28+ years old. It is registered with the Registrar of Companies, Gwalior.
Quest Laboratories has 1 deal on record (1 ipo); the latest was in May 2024.
The peers of Quest Laboratories by revenue are STG Pharmagenerics Private Limited, Horizon Bioceuticals Pvt Ltd, Inventaa Industries Private Limited, Novus Life Sciences Private Limited, Chemtech Intermediates Limited and 5 more, all in the Pharma industry (Formulations).